On July 2013, ALTEN (www.alten.com) acquired the European Contract Research Organization Advanced Drug & Device Services (ADDS) and regroups its Life Sciences solutions in a new structure, APROVA (www.aprova-cro.com), headquartered in Brussels.


With annual revenues of 1 198 MÄ in 2012 and 15 950 co-workers worldwide (among them 88% of high-level engineers and scientists working for large companies), ALTEN is the European leader in Engineering and Consulting.